Table 2.
Plk1 kinase Inhibitors in preclinical development
a Interacting residues by hydrogen bonding etc. are evaluated based on crystal structure or homology models.
Plk1 kinase Inhibitors in preclinical development
a Interacting residues by hydrogen bonding etc. are evaluated based on crystal structure or homology models.